Edivoxetine Uses, Dosage, Side Effects and more
Edivoxetine is a drug which acts as a selective norepinephrine reuptake inhibitor and is currently under development by Eli Lilly for attention-deficit hyperactivity disorder (ADHD) and as an antidepressant treatment. Edivoxetine failed to be approved for major depressive disorder after phase III clinical trials in 2012.
| Trade Name | Edivoxetine |
| Generic | Edivoxetine |
| Edivoxetine Other Names | Edivoxetine |
| Type | |
| Formula | C18H26FNO4 |
| Weight | Average: 339.407 Monoisotopic: 339.184586484 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
